Kelli Zhao
Policy Analyst, Economics of Biopharmaceutical Innovation
Email: [email protected]
Zhao is a policy analyst focusing on the economics of biopharmaceutical innovation. She holds a M.Sc. in international health policy (health economics) from the London School of Economics and Political Sciences and a B.A. in economics from the University of Sydney. Previously she worked as a research assistant at The George Institute for Global Health in Australia.
Recent Publications
March 20, 2023
The Economics of Biopharmaceutical Innovation: Symposium Report
Investments in biopharmaceutical innovation and expenditures on medicines themselves both produce tremendous societal returns. Maintaining the robust innovation ecosystem necessary to capitalize on these benefits requires the right mix of “push” and “pull” incentives.
